Cargando…

Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?

Alzheimer’s disease (AD) is a complex, multi-factorial disease affecting various brain systems. This complexity implies that successful therapies must be directed against several core neuropathological targets rather than single ones. The scientific community has made great efforts to identify the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerovic, Milica, Forloni, Gianluigi, Balducci, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813195/ https://www.ncbi.nlm.nih.gov/pubmed/31680937 http://dx.doi.org/10.3389/fnagi.2019.00284

Ejemplares similares

Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
por: Balducci, Claudia, et al.
Publicado: (2019)

Alzheimer’s Disease, Oligomers, and Inflammation
por: Forloni, Gianluigi, et al.
Publicado: (2018)

Oligomeropathies, inflammation and prion protein binding
por: Forloni, Gianluigi, et al.
Publicado: (2022)

Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease
por: Fernando, Kurukulasooriya Kavindya Madushani, et al.
Publicado: (2021)

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age
por: Costa, Giulia, et al.
Publicado: (2018)

Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues
por: Liang, Junyi, et al.
Publicado: (2023)

Adaptive Brain Shut-Down Counteracts Neuroinflammation in the Near-Term Ovine Fetus
por: Xu, Alex, et al.
Publicado: (2014)

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
por: Megur, Ashwinipriyadarshini, et al.
Publicado: (2020)

Periodontitis and Alzheimer’s Disease: A Possible Comorbidity between Oral Chronic Inflammatory Condition and Neuroinflammation
por: Teixeira, Francisco B., et al.
Publicado: (2017)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Gut-Brain Axis: Possible Role of Gut Microbiota in Perioperative Neurocognitive Disorders
por: Wang, Xiao-qing, et al.
Publicado: (2021)

Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
por: Wu, Shaochang, et al.
Publicado: (2021)

Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
por: Zhu, Feiqi, et al.
Publicado: (2020)

Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
por: Morales, Inelia, et al.
Publicado: (2014)

Brain injury, neuroinflammation and Alzheimer's disease
por: Breunig, Joshua J., et al.
Publicado: (2013)

Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
por: Wang, Xinyi, et al.
Publicado: (2019)

Alzheimer’s disease: from basic science to precision medicine approach
por: Forloni, Gianluigi
Publicado: (2020)

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
por: Saha, Sarmistha, et al.
Publicado: (2022)

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
por: Oliveira, Bruna Stefane Alves de, et al.
Publicado: (2022)

Neuroinflammation and Brain Functional Disconnection in Alzheimer’s Disease
por: Baglio, Francesca, et al.
Publicado: (2013)

Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
por: Marttinen, Mikael, et al.
Publicado: (2018)

Porphyromonas gingivalis-Induced Neuroinflammation in Alzheimer’s Disease
por: Olsen, Ingar
Publicado: (2021)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

Editorial: Gut microbiota as a therapeutic target in neuropsychiatric disorders: current status and future directions
por: Cai, Hualin, et al.
Publicado: (2023)

Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels
por: Bonfili, Laura, et al.
Publicado: (2017)

Two Curcumin Extracts Modify Composition of Gut Microbiota, Tight Junction Protein, and Neuroinflammation in Rats With Neuropathic Pain: Microbiota-Gut-Brain Axis
por: Shen, Chwan-Li, et al.
Publicado: (2022)

Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota
por: Bao, Zeyu, et al.
Publicado: (2022)

Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation
por: Calvello, Rosa, et al.
Publicado: (2017)

Therapeutic Implications of Probiotics in the Gut Microbe-Modulated Neuroinflammation and Progression of Alzheimer’s Disease
por: Murai, Toshiyuki, et al.
Publicado: (2023)

Prebiotic Effect of Fructooligosaccharides from Morinda officinalis on Alzheimer’s Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis
por: Chen, Diling, et al.
Publicado: (2017)

Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
por: Frausto, Dulce M., et al.
Publicado: (2021)

Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
por: Ahmed, Md. Mahiuddin, et al.
Publicado: (2021)

Editorial: Gut-microbiota-brain axis in depression: mechanisms and possible therapies
por: Pesarico, Ana Paula, et al.
Publicado: (2023)

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
por: Weng, Shiting, et al.
Publicado: (2022)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
por: Hou, Min, et al.
Publicado: (2021)

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model
por: Chu, Xixia, et al.
Publicado: (2022)

Neural cortical organoids from self-assembling human iPSC as a model to investigate neurotoxicity in brain ischemia
por: De Paola, Massimiliano, et al.
Publicado: (2023)

Autophagy in Zika Virus Infection: A Possible Therapeutic Target to Counteract Viral Replication
por: Gratton, Rossella, et al.
Publicado: (2019)

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
por: Pak, Victoria M., et al.
Publicado: (2020)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tplbhvt93arjuks2fhga0lt6l2